Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis.

ABSTRACT:

Background

Appropriate dialysis prescription in the transitional setting from chronic kidney disease to end-stage kidney disease is still challenging. Conventional thrice-weekly haemodialysis (HD) might be associated with rapid loss of residual kidney function (RKF) and high mortality. The benefits and risks of incremental HD compared with conventional HD were explored in this systematic review and meta-analysis.

Methods

We searched MEDLINE, Scopus and Cochrane Central Register of Controlled Trials up to April 2023 for studies that compared the impacts of incremental (once- or twice-weekly HD) and conventional thrice-weekly HD on cardiovascular events, RKF, vascular access complications, quality of life, hospitalization and mortality.

Results

A total of 36 articles (1

SUBMITTER: Takkavatakarn K 

PROVIDER: S-EPMC10768771 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature